SGRY
Income statement / Annual
Last year (2025), Surgery Partners Inc's total revenue was $3.31 B,
an increase of 6.24% from the previous year.
In 2025, Surgery Partners Inc's net income was -$77.90 M.
See Surgery Partners Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.31 B |
$3.11 B |
$2.74 B |
$2.54 B |
$2.23 B |
$1.86 B |
$1.83 B |
$1.77 B |
$1.34 B |
$1.15 B |
| Cost of Revenue |
$2.54 B
|
$2.37 B
|
$2.10 B
|
$1.96 B
|
$1.73 B
|
$1.48 B
|
$1.41 B
|
$1.36 B
|
$1.01 B
|
$821.20 M
|
| Gross Profit |
$765.00 M
|
$745.60 M
|
$647.50 M
|
$574.90 M
|
$491.40 M
|
$379.80 M
|
$423.80 M
|
$410.03 M
|
$327.42 M
|
$324.24 M
|
| Gross Profit Ratio |
0.23
|
0.24
|
0.24
|
0.23
|
0.22
|
0.2
|
0.23
|
0.23
|
0.24
|
0.28
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$522.70 M
|
$138.70 M
|
$120.90 M
|
$102.20 M
|
$104.00 M
|
$97.10 M
|
$88.60 M
|
$93.56 M
|
$75.95 M
|
$60.25 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$522.70 M
|
$138.70 M
|
$120.90 M
|
$102.20 M
|
$104.00 M
|
$97.10 M
|
$88.60 M
|
$93.56 M
|
$75.95 M
|
$60.25 M
|
| Other Expenses |
-$147.20 M
|
$258.10 M
|
$198.60 M
|
$127.50 M
|
$85.20 M
|
$99.70 M
|
$99.30 M
|
$63.67 M
|
$25.33 M
|
-$3.73 M
|
| Operating Expenses |
$375.50 M
|
$396.80 M
|
$319.50 M
|
$229.70 M
|
$189.20 M
|
$196.80 M
|
$187.90 M
|
$157.23 M
|
$156.37 M
|
$123.66 M
|
| Cost And Expenses |
$2.92 B
|
$2.77 B
|
$2.42 B
|
$2.19 B
|
$1.92 B
|
$1.68 B
|
$1.60 B
|
$1.52 B
|
$1.17 B
|
$944.85 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$272.60 M
|
$201.70 M
|
$193.00 M
|
$234.90 M
|
$221.00 M
|
$201.80 M
|
$178.90 M
|
$147.00 M
|
$117.67 M
|
$100.57 M
|
| Depreciation & Amortization |
$176.00 M
|
$152.60 M
|
$118.10 M
|
$114.80 M
|
$98.80 M
|
$94.80 M
|
$76.50 M
|
$67.44 M
|
$51.93 M
|
$39.55 M
|
| EBITDA |
$565.50 M |
$501.40 M |
$446.10 M |
$460.00 M |
$401.00 M |
$277.80 M |
$310.00 M |
$144.68 M |
$251.88 M |
$245.23 M |
| EBITDA Ratio |
0.17
|
0.16
|
0.16
|
0.18
|
0.18
|
0.15
|
0.17
|
0.08
|
0.19
|
0.21
|
| Operating Income Ratio |
0.12
|
0.11
|
0.12
|
0.14
|
0.14
|
0.1
|
0.13
|
0.04
|
0.12
|
0.17
|
| Total Other Income/Expenses Net |
-$272.60 M
|
-$201.70 M
|
-$193.00 M
|
-$234.90 M
|
-$221.00 M
|
-$201.80 M
|
-$181.30 M
|
-$147.00 M
|
-$75.95 M
|
-$104.30 M
|
| Income Before Tax |
$116.90 M
|
$147.10 M
|
$135.00 M
|
$110.30 M
|
$81.20 M
|
-$18.80 M
|
$54.60 M
|
-$69.17 M
|
$82.29 M
|
$92.18 M
|
| Income Before Tax Ratio |
0.04
|
0.05
|
0.05
|
0.04
|
0.04
|
-0.01
|
0.03
|
-0.04
|
0.06
|
0.08
|
| Income Tax Expense |
$18.00 M
|
$134.60 M
|
-$300.00 K
|
$23.30 M
|
$10.50 M
|
-$20.10 M
|
$9.50 M
|
$26.46 M
|
$53.55 M
|
$7.10 M
|
| Net Income |
-$77.90 M
|
-$168.10 M
|
-$11.90 M
|
-$54.60 M
|
-$70.90 M
|
-$116.10 M
|
-$74.80 M
|
-$205.71 M
|
-$52.99 M
|
$9.45 M
|
| Net Income Ratio |
-0.02
|
-0.05
|
-0
|
-0.02
|
-0.03
|
-0.06
|
-0.04
|
-0.12
|
-0.04
|
0.01
|
| EPS |
-0.61 |
-1.33 |
-0.0947 |
-0.59 |
-1.12 |
-3.19 |
0.95 |
-4.28 |
-1.09 |
0.2 |
| EPS Diluted |
-0.61 |
-1.33 |
-0.0947 |
-0.59 |
-1.12 |
-3.19 |
0.95 |
-4.28 |
-1.08 |
0.2 |
| Weighted Average Shares Out |
$127.21 M
|
$126.12 M
|
$125.61 M
|
$91.95 M
|
$72.43 M
|
$48.78 M
|
$48.28 M
|
$48.03 M
|
$48.69 M
|
$48.02 M
|
| Weighted Average Shares Out Diluted |
$127.21 M
|
$126.12 M
|
$125.61 M
|
$91.95 M
|
$72.43 M
|
$48.78 M
|
$48.28 M
|
$48.03 M
|
$49.00 M
|
$48.19 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
